Login / Signup
CS12192: A novel selective and potent JAK3 inhibitor mitigates acute graft-versus-host disease in bone marrow transplantation.
Shengjian Huang
Qianjiao Yang
You Zhou
Lingjie Li
Song Shan
Published in:
Transplant immunology (2024)
CS12192 is a novel, potent and selective JAK3 inhibitor demonstrating great potential to mitigate acute GVHD.
Keyphrases
</>
liver failure
bone marrow
respiratory failure
drug induced
aortic dissection
mesenchymal stem cells
hepatitis b virus
stem cells
cell therapy
extracorporeal membrane oxygenation
intensive care unit
mechanical ventilation